{"disease":{"id":"nsclc-with-copd","name":"nsclc with copd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05578222","title":"Pembrolizumab as First-line Treatment for Advanced NSCLC Complicated With COPD","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Tianjin Chest Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}